These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


954 related items for PubMed ID: 18836868

  • 21. Does preterm birth influence the response to growth hormone treatment in short, small for gestational age children?
    de Kort SW, Willemsen RH, van der Kaay DC, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):582-7. PubMed ID: 19067725
    [Abstract] [Full Text] [Related]

  • 22. Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years.
    de Zegher F, Albertsson-Wikland K, Wollmann HA, Chatelain P, Chaussain JL, Löfström A, Jonsson B, Rosenfeld RG.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2816-21. PubMed ID: 10946888
    [Abstract] [Full Text] [Related]

  • 23. Cost-effectiveness of somatropin for the treatment of short children born small for gestational age.
    Christensen T, Buckland A, Bentley A, Djurhuus C, Baker-Searle R.
    Clin Ther; 2010 Jun; 32(6):1068-82. PubMed ID: 20637961
    [Abstract] [Full Text] [Related]

  • 24. Sensitivity to IGF-I in short children born small for gestational age.
    Ranke MB.
    J Endocrinol Invest; 2006 Jun; 29(1 Suppl):21-6. PubMed ID: 16615303
    [Abstract] [Full Text] [Related]

  • 25. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Jun; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 26. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D, Garel C, Limoni C, Czernichow P, Léger J.
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [Abstract] [Full Text] [Related]

  • 27. Growth hormone therapy in short children born small for gestational age.
    de Zegher F, Ong KK, Ibáñez L, Dunger DB.
    Horm Res; 2006 May; 65 Suppl 3():145-52. PubMed ID: 16612128
    [Abstract] [Full Text] [Related]

  • 28. Craniofacial growth in short children born small for gestational age: two years follow-up after high-dose growth hormone treatment.
    Van Erum R, Carels C, Verbeke G, de Zegher F.
    J Craniofac Genet Dev Biol; 1997 May; 17(4):184-9. PubMed ID: 9493076
    [Abstract] [Full Text] [Related]

  • 29. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F, Du Caju MV, Heinrichs C, Maes M, De Schepper J, Craen M, Vanweser K, Malvaux P, Rosenfeld RG.
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [Abstract] [Full Text] [Related]

  • 30. [Growth hormone treatment of short children born small for gestational age].
    Christesen HB, Jensen RB, Birkebaek NH, Hertel NT, Main KM, Mortensen HB, Naeraa RW, Juul A.
    Ugeskr Laeger; 2006 Feb 27; 168(9):889-95. PubMed ID: 16513050
    [Abstract] [Full Text] [Related]

  • 31. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV, Dana K, Frane J, Lippe B.
    Pediatr Endocrinol Rev; 2008 Sep 27; 6(1):5-8. PubMed ID: 18806719
    [Abstract] [Full Text] [Related]

  • 32. Should recombinant human growth hormone therapy be used in short small for gestational age children?
    Johnston LB, Savage MO.
    Arch Dis Child; 2004 Aug 27; 89(8):740-4. PubMed ID: 15269075
    [Abstract] [Full Text] [Related]

  • 33. Final height in short children born small for gestational age treated with growth hormone.
    Dahlgren J, Wikland KA, Swedish Study Group for Growth Hormone Treatment.
    Pediatr Res; 2005 Feb 27; 57(2):216-22. PubMed ID: 15585685
    [Abstract] [Full Text] [Related]

  • 34. [Infants born with development disorders. What about the long-term statural development? What are the therapeutic possibilities?].
    Heinrichs C.
    Rev Med Brux; 1998 Dec 27; 19(6):471-3. PubMed ID: 9916493
    [Abstract] [Full Text] [Related]

  • 35. Effect of different growth hormone dosages on the growth velocity in children born small for gestational age.
    Bozzola E, Lauriola S, Messina MF, Bona G, Tinelli C, Tatò L.
    Horm Res; 2004 Dec 27; 61(2):98-102. PubMed ID: 14654718
    [Abstract] [Full Text] [Related]

  • 36. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.
    van der Kaay DC, Hendriks AE, Ester WA, Leunissen RW, Willemsen RH, de Kort SW, Paquette JR, Hokken-Koelega AC, Deal CL.
    Growth Horm IGF Res; 2009 Jun 27; 19(3):198-205. PubMed ID: 18929499
    [Abstract] [Full Text] [Related]

  • 37. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
    Trollmann R, Bakker B, Lundberg M, Doerr HG.
    Pediatr Rehabil; 2006 Jun 27; 9(2):144-8. PubMed ID: 16449073
    [Abstract] [Full Text] [Related]

  • 38. Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age.
    Cutfield WS, Jackson WE, Jefferies C, Robinson EM, Breier BH, Richards GE, Hofman PL.
    J Pediatr; 2003 Feb 27; 142(2):113-6. PubMed ID: 12584529
    [Abstract] [Full Text] [Related]

  • 39. Growth hormone treatment and fat redistribution in children born small for gestational age.
    De Schepper J, Thomas M, Beckers D, Craen M, Maes M, de Zegher F.
    J Pediatr; 2008 Mar 27; 152(3):327-30. PubMed ID: 18280835
    [Abstract] [Full Text] [Related]

  • 40. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G.
    Horm Res; 2009 Mar 27; 71(3):167-72. PubMed ID: 19188742
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 48.